GenWay Biotech
| About us | GenWay offers both custom and catalog products. We recently licensed to Beckman Coulter a novel product line of IgY-based immunoaffinity protein separation (Seppro-TM) for highly specific removal of abundant plasma, serum or cellular proteins, which is a critical step in proteomic profiling and biomarker/drug target discovery. By applying tissue microarray technology, GenWay also enables target validation and screening of important disease-related proteins. Potential partners and clients may also be interested GenWay services including IHC/ICC validation of protein targets; and proteomic research services, including sample preparation,2D-gel analysis, and LC or HPLC-coupled Mass Spectrometry for protein identification and profiling. |
|---|---|
| Industry Focus | Bio-technology Products, Pharmaceutical Chemicals |
| Business Type | Manufacturer |
| Products/Services | Custom and catalog recombinant proteins, polyclonal IgY antibodies & protein partitioning and proteomics services |
| Our Markets | North America |
| No. of Employees | 11 - 50 People |
| Annual Sales Range(USD) | US$1 Million - US$2.5 Million |
| Year Established | 1998 |
| Legal Representative(CEO) | Wei-Wei Zhang |
| Certificates | Delaware |
